Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Hofbauer

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Leukemia|November 15, 2014
Myelodysplasia is in the niche: novel concepts and emerging therapiesE Bulycheva, M Rauner, H Medyouf, et al.
Diabetologia|June 25, 2011
Nuclear factor of activated T cells mediates oxidised LDL-induced calcification of vascular smooth muscle cellsC Goettsch, M Rauner, C Hamann, et al.
Endocrinology|December 7, 2000
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulatedF Gori, L C Hofbauer, C R Dunstan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 9, 2020
Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European expertsT Thomas, E Casado, P Geusens, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 31, 1997
[Endocrinologic and metabolic complications of Alagille syndrome]L C Hofbauer, A Mrozek-Lasota, T Jelinek, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 26, 2000
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorptionL C Hofbauer, S Khosla, C R Dunstan, et al.
Endocrine|September 18, 2007
Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell linesS Hoffmann, A Burchert, A Wunderlich, et al.
Bone|September 24, 1999
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cellsL C Hofbauer, D L Lacey, C R Dunstan, et al.
Endocrinology|August 28, 1999
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cellsL C Hofbauer, S Khosla, C R Dunstan, et al.
Endocrine|December 23, 2006
Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cellsS Hoffmann, K Maschuw, I Hassan, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Leukemia|November 15, 2014
Myelodysplasia is in the niche: novel concepts and emerging therapiesE Bulycheva, M Rauner, H Medyouf, et al.
Diabetologia|June 25, 2011
Nuclear factor of activated T cells mediates oxidised LDL-induced calcification of vascular smooth muscle cellsC Goettsch, M Rauner, C Hamann, et al.
Endocrinology|December 7, 2000
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulatedF Gori, L C Hofbauer, C R Dunstan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 9, 2020
Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European expertsT Thomas, E Casado, P Geusens, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 31, 1997
[Endocrinologic and metabolic complications of Alagille syndrome]L C Hofbauer, A Mrozek-Lasota, T Jelinek, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 26, 2000
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorptionL C Hofbauer, S Khosla, C R Dunstan, et al.
Endocrine|September 18, 2007
Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell linesS Hoffmann, A Burchert, A Wunderlich, et al.
Bone|September 24, 1999
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cellsL C Hofbauer, D L Lacey, C R Dunstan, et al.
Endocrinology|August 28, 1999
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cellsL C Hofbauer, S Khosla, C R Dunstan, et al.
Endocrine|December 23, 2006
Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cellsS Hoffmann, K Maschuw, I Hassan, et al.
Pageof 12